Incidental venous thromboembolic events in cancer patients: what we know in 2016.
暂无分享,去创建一个
[1] A. Shinagare,et al. Risk of recurrent venous thromboembolism and major hemorrhage in cancer‐associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients , 2016, Journal of thrombosis and haemostasis : JTH.
[2] L. Kroft,et al. Reliability of diagnosing incidental pulmonary embolism in cancer patients. , 2015, Thrombosis research.
[3] A. Khorana,et al. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH , 2015, Journal of thrombosis and haemostasis : JTH.
[4] Gary H Lyman,et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] A. Khorana,et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer , 2013, Journal of thrombosis and haemostasis : JTH.
[6] A. Khorana,et al. Incidental venous thromboembolism in oncology patients , 2012, Journal of thrombosis and haemostasis : JTH.
[7] P. Prandoni,et al. Is Incidentally Detected Pulmonary Embolism in Cancer Patients Less Severe? A Case-Control Study , 2012, Cancer investigation.
[8] W. Ageno,et al. Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: a retrospective cohort study , 2012, Journal of thrombosis and haemostasis : JTH.
[9] P. Razavi,et al. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] D. Feldman,et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] F. Gleeson,et al. The clinician's response to a report of an incidental pulmonary embolism detected on multidetector CT , 2011, Postgraduate Medical Journal.
[12] S. Kahn,et al. The management of a sub‐segmental pulmonary embolism: a cross‐sectional survey of Canadian thrombosis physicians , 2011, Journal of Thrombosis and Haemostasis.
[13] O. Dekkers,et al. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] W. Ageno,et al. Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer , 2011, Journal of thrombosis and haemostasis : JTH.
[15] H. Abdel-Razeq,et al. Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience , 2011, Vascular health and risk management.
[16] P. Razavi,et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi‐row detector computed tomography scanning , 2011, Journal of thrombosis and haemostasis : JTH.
[17] A. Shaw,et al. Incidental pulmonary emboli in lymphoma patients are associated with aggressive disease and poor prognosis , 2010, Journal of thrombosis and haemostasis : JTH.
[18] Anthony A Donato,et al. Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. , 2010, Thrombosis research.
[19] J. Ahn,et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy. , 2010, Lung cancer.
[20] S. Iacobelli,et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy , 2010, Thrombosis and Haemostasis.
[21] D. Anderson,et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta‐analysis of the management outcome studies , 2010, Journal of thrombosis and haemostasis : JTH.
[22] A. Khorana,et al. High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients , 2010, Journal of thrombosis and haemostasis : JTH.
[23] H. Büller,et al. Incidental venous thromboembolism in cancer patients: prevalence and consequence. , 2010, Thrombosis research.
[24] M. Gianni,et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. , 2010, Thrombosis research.
[25] A. Khorana,et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy , 2007, Journal of thrombosis and haemostasis : JTH.
[26] C. Vigen,et al. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] F. Rosendaal,et al. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study , 2006, Journal of thrombosis and haemostasis : JTH.
[28] J. Heit. Cancer and venous thromboembolism: scope of the problem. , 2005, Cancer control : journal of the Moffitt Cancer Center.
[29] Lacey Washington,et al. Clinicians' response to radiologists' reports of isolated subsegmental pulmonary embolism or inconclusive interpretation of pulmonary embolism using MDCT. , 2005, AJR. American journal of roentgenology.
[30] M. Prins,et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.
[31] Paolo Prandoni,et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. , 2002, Blood.
[32] M Gent,et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] A A Rimm,et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. , 1999, Medicine.
[34] P. Stein,et al. Incidence of venous thromboembolism in patients hospitalized with cancer. , 2006, The American journal of medicine.